Vascular targeting therapies for treatment of malignant disease.
Brown
Stephen L
SL
Kolozsvary
Andrew
A
Kim
Jae Ho
JH
D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D010087:Oxides / Q000009:adverse effects / Q000627:therapeutic use*
D020533:Angiogenesis Inhibitors; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide